NFL Biosciences: Financial calendar for the first half of 2023
18 January 2023 - 3:45AM
NFL Biosciences: Financial calendar for the first half of 2023
NFL Biosciences: Financial calendar for the first half of
2023
NFL BIOSCIENCES (Euronext Growth Paris –
FR0014003XT0 – ALNFL), a biopharmaceutical company
developing botanical drugs for the treatment of addictions, and
particularly NFL-101, its drug candidate for smoking cessation,
presents its financial communication calendar for the first half of
2023.
- Annual results 2022
(year ending December 31, 2022): Tuesday, April 25th 2023 before
the opening of the stock market
- Annual General
Shareholders Meeting: Tuesday, June 27th 2023 in Montpellier
(FR)
The financial communication calendar for the
rest of the year will be announced during the summer of 2023.
About NFL Biosciences
NFL Biosciences is a biopharmaceutical company
based in the Montpellier area which develops botanical drug
candidates for the treatment of addictions. NFL Biosciences'
ambition is to bring new, natural, safer and more effective
therapeutic solutions to the entire world population, including
low- and middle-income countries. Its most advanced product, called
NFL-101, is a standardized, nicotine-free tobacco leaf extract
protected by two patent families. NFL Biosciences intends to offer
smokers who want to quit a natural, safe, easy-to-administer and
personalized alternative. NFL Biosciences is also developing
NFL-301, a natural drug candidate for the reduction of alcohol
consumption and has a drug development project for the treatment of
cannabis use disorders.
The shares of NFL Biosciences are listed on
Euronext Growth Paris (FR0014003XT0 – ALNFL). Find out more at
www.nflbiosciences.com
Contacts
Bruno Lafont – info@nflbiosciences.com - +33 4
11 93 76 67 Agence
Calyptus – nflbio@calyptus.net - +33 1 53 65 68 68
- NFLBiosciences_CP_Agenda-financier_EN_DEF
NFL Biosciences (EU:ALNFL)
Historical Stock Chart
From Jul 2024 to Aug 2024
NFL Biosciences (EU:ALNFL)
Historical Stock Chart
From Aug 2023 to Aug 2024
Real-Time news about NFL Biosciences SA (Euronext): 0 recent articles
More News Articles